Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2024
Jul. 31, 2023
Current assets:    
Cash and cash equivalents $ 52,371 $ 82,373
Cash in escrow 5,000
Accounts receivable, net 3,988 4,808
Inventories, net 6,832 7,939
Prepaid expenses and other current assets, including $1,000 restricted cash at July 31, 2023 1,840 3,336
Total current assets 70,031 98,456
Property, plant, and equipment, net 12,367 13,086
Right-of-use assets 2,836 3,626
Other assets, including $5,000 cash in escrow at July 31, 2023 530 5,745
Non-current assets of discontinued operations, net 967
Total assets 85,764 121,880
Current liabilities:    
Accounts payable – trade 1,376 3,575
Accrued liabilities 5,714 11,743
Current portion of operating lease liabilities 841 980
Other current liabilities 76 75
Convertible debentures 2,514
Current liabilities of discontinued operations, net 16,787 21,102
Total current liabilities 24,794 39,989
Operating lease liabilities, non-current 2,403 3,160
Long term debt, net 189 269
Non-current liabilities of discontinued operations, net 2,266
Total liabilities 29,652 43,418
Commitments and contingencies – see Notes 16 and 17
Stockholders’ equity:    
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued and outstanding: 52,244,074 at July 31, 2024 and 49,997,631 at July 31, 2023 521 499
Additional paid-in capital 348,134 344,435
Accumulated deficit (294,428) (268,350)
Accumulated other comprehensive income 1,885 1,878
Total stockholders’ equity 56,112 78,462
Total liabilities and stockholders’ equity $ 85,764 $ 121,880